HealthEquity, Inc. (HQY)
NASDAQ: HQY · IEX Real-Time Price · USD
80.26
+1.22 (1.54%)
At close: Apr 26, 2024, 4:00 PM
79.91
-0.35 (-0.44%)
After-hours: Apr 26, 2024, 7:52 PM EDT
HealthEquity Revenue
In the fiscal year ending January 31, 2024, HealthEquity had annual revenue of $999.59M with 16.00% growth. Revenue in the quarter ending January 31, 2024 was $262.39M with 12.21% year-over-year growth.
Revenue (ttm)
$999.59M
Revenue Growth
+16.00%
P/S Ratio
6.92
Revenue / Employee
$317,329
Employees
3,150
Market Cap
6.92B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 999.59M | 137.84M | 16.00% |
Jan 31, 2023 | 861.75M | 105.19M | 13.90% |
Jan 31, 2022 | 756.56M | 22.99M | 3.13% |
Jan 31, 2021 | 733.57M | 201.58M | 37.89% |
Jan 31, 2020 | 531.99M | 244.75M | 85.21% |
Jan 31, 2019 | 287.24M | 57.72M | 25.15% |
Jan 31, 2018 | 229.53M | 51.16M | 28.68% |
Jan 31, 2017 | 178.37M | 51.58M | 40.69% |
Jan 31, 2016 | 126.79M | 38.93M | 44.31% |
Jan 31, 2015 | 87.86M | 25.84M | 41.67% |
Jan 31, 2014 | 62.02M | 15.93M | 34.56% |
Jan 31, 2013 | 46.09M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jazz Pharmaceuticals | 3.83B |
The Ensign Group | 3.73B |
Acadia Healthcare Company | 2.93B |
Masimo | 2.05B |
Exelixis | 1.83B |
Globus Medical | 1.57B |
Inspire Medical Systems | 624.80M |
Intra-Cellular Therapies | 464.37M |
HQY News
- 24 days ago - Benefits Leaders Believe in Power of AI, Considering Data Privacy and Accuracy - GlobeNewsWire
- 5 weeks ago - HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - HealthEquity Sets Date to Announce Fiscal Year End Results - GlobeNewsWire
- 2 months ago - HealthEquity Reports Year-End Sales Metrics - GlobeNewsWire
- 3 months ago - HealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor Day - GlobeNewsWire
- 4 months ago - 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts - Market Watch
- 4 months ago - HealthEquity Forum to Unveil 2024's Top Employee Benefits Trends: AI, Cost Management, and More - GlobeNewsWire
- 5 months ago - HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results - GlobeNewsWire